From CURE to MATCH: ADP Receptor Antagonists as the Treatment of Choice for High-Risk Atherothrombotic Patients

Publisher： Karger

E-ISSN： 1421-9786|13|1|22-26

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.13, Iss.1, 2002-01, pp. : 22-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefit of ADP Receptor Antagonists in Atherothrombotic Patients: New Evidence

By  

Cerebrovascular Diseases, Vol. 11, Iss. 2, 2001-04 ,pp. : 5-10

Karger

Access to resources Recommend Favorite

Treatment of High-Risk Hypertensive Patients: Unresolved Issues Revised by Staging the Risk

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 1, 2006-01 ,pp. : 13-19

Adis International

Access to resources Recommend Favorite

Leukotriene Receptor Antagonists: A Good Choice in the Treatment of Premenstrual Asthma?

By Pasaoglu Gulden   Mungan Dilsad   Abadoglu Oznur   Misirligil Zeynep  

Journal of Asthma, Vol. 45, Iss. 2, 2008-03 ,pp. : 95-99

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

By Storey Robert F.   Wilcox Robert G.   Heptinstall Stan  

Platelets, Vol. 13, Iss. 7, 2002-11 ,pp. : 407-413

Informa Healthcare

Access to resources Recommend Favorite

Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke (MATCH): Study Design and Baseline Data

By  

Cerebrovascular Diseases, Vol. 17, Iss. 2-3, 2003-12 ,pp. : 253-261

Karger

Access to resources Recommend Favorite